生物分析的分析方法
准备好的强大资源。
Validated Bioanalytical Assays to Support Your COVID-19 Therapy Development
Saving precious time in meeting urgent demand
Abacavir / Darunavir / etravirine / Lamivudine / Nevirapine / Saquinavir / Stavudine / Zidovudine - Combo方法 Amprenavir Amprenavir / Ritonavir – combo method Azithromycin Emtricitabine Emtricitabine / Tenofovir – combo method Lopinavir / Ritonavir - 组合方法 Proprietary methods approved for use in COVID-19 trials: |
Maraviroc Raltegravir 利巴韦林 Rilpivirine Ritonavir 替诺福韦 |
From preclinical research through clinical development, we’re here to help you at every stage of the continuum to deliver accurate, on-time results and advance your program. To meet your program’s requirements, our GLP, nonproprietary methods have been developed according to FDA Crystal City and current regulatory guidelines. With Covance as your partner, you’ll benefit from our expert scientific team and state-of-the-art technologies to support your DDI, concomitant drugs and generics studies.
For your convenience, we’ve organized our nonproprietary bioanalytical methods into two categories: single analyte methods and multi-analyte methods, accessible in the PDFs below. These lists now include therapeutic area and disease.